Clinical Predictors of Severity in Pediatric Community-Acquired Pneumonia at Assiut University Ch… (NCT07279675) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Clinical Predictors of Severity in Pediatric Community-Acquired Pneumonia at Assiut University Children's Hospital
67 participantsStarted 2025-12-01
Plain-language summary
This study aims to identify the clinical factors that predict the severity of community-acquired pneumonia (CAP) in pediatric patients. Children admitted to Assiut University Children's Hospital with a diagnosis of CAP will be evaluated through clinical examination, vital signs, laboratory investigations, and radiological findings. The study focuses on determining which clinical features are associated with more severe disease, higher need for oxygen therapy, intensive care admission, or complications. Understanding these predictors may help clinicians recognize severe cases earlier and improve patient management and outcomes.
Who can participate
Age range
1 Month – 5 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Children aged 1 month to 5 years.
* Children of both sexes
* Onset of illness in the community, not more than 48 hours after hospital admission.
Exclusion Criteria:
* Children below 1 month, as neonatal pneumonia differs in pathology and management from CAP.
* Children with hospital-acquired pneumonia
* Known primary or secondary immunodeficiency
* Children with chronic respiratory diseases (as cystic fibrosis, bronchiectasis) or congenital lung malformations.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Association of Severity Scores with Clinical Outcomes
Timeframe: 14 days from enrollment (typical hospital stay and outpatient follow-up)
2
Severity of Community-Acquired Pneumonia Assessed by the Respiratory Index of Severity in Children (RISC)
Timeframe: 4 days from enrollment (typical hospital stay and outpatient follow-up)